Genmab A/S Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Genmab A/S (GMAB) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of $332.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-02-17
DKK
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month as first filed | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|---|
| 2024-12-31 | -6.05B DKK 6-K · filed 2025-02-12 | ||
| 2024-06-30 | -10.83B DKK 6-K · filed 2024-08-08 | ||
| 2023-12-31 | 5.49B DKK 6-K · filed 2025-02-12 | ||
| 2023-06-30 | 1.22B DKK 6-K · filed 2024-08-08 | ||
| 2022-12-31 | 362.00M DKK 6-K · filed 2025-02-12 | ||
| 2022-06-30 | 25.00M DKK 6-K · filed 2023-08-03 | ||
| 2021-12-31 | 847.00M DKK 6-K · filed 2024-02-14 | ||
| 2021-06-30 | 2.05B DKK 6-K · filed 2022-08-10 | ||
| 2020-12-31 | 4.15B DKK 6-K · filed 2023-02-22 | ||
| 2020-06-30 | 3.10B DKK 6-K · filed 2021-08-11 | ||
| 2019-12-31 | 3.00B DKK 6-K · filed 2022-02-16 | ||
| 2019-06-30 | 62.00M DKK 6-K · filed 2020-08-12 | 61.56M DKK 6-K · filed 2019-08-14 | |
| 2018-12-31 | -834.00M DKK 6-K · filed 2021-02-23 | ||
| 2018-06-30 | -273.25M DKK 6-K · filed 2019-08-14 | ||
| 2017-12-31 | 1.14B DKK 20-F · filed 2020-03-30 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|
| 2025-12-31 | $332.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | -$87.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | -$887.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | -$1.57B 6-K · filed 2025-08-07 | |
| 2023-12-31 | $797.00M 20-F · filed 2026-02-17 |